Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
This month we are pleased to give a huge thank you to Ketki Patel!
Ketki Patel, MHA, is a Program Operations Specialist/Post Award Specialist for the University of Washington Thoracic, Head and Neck Oncology Research Program in Seattle, Washington.
Ketki is an experienced Patient Financial Advocate with a demonstrated history of working with clinical trials/research, medical oncology, and holds knowledge in prior-authorization of inpatient and outpatient chemotherapy and appealing all types of claim denials. She has experience working with the drug manufacturers for drug assistance and copay assistance in the hospital billing setting. She has her Masters in Healthcare Administration and is a Certified Transplant Financial Coordinator.
Ketki has offered GRACE excellent information on navigating the maze of the continuously changing payer landscape; from treatments to medication, genetic testing, and dealing with clinical trials. More information from Ketki will be coming soon - and we are so thrilled to have her as one of our contributors. We are excited to see what comes next.
See Ketki's contributions to GRACE here!
Ketki, Thank you! Your articles on financial help for people dealing with cancer mean so much for our community. For those people dealing with the journey of a cancer diagnosis, the addition of trying to understand the financial burdens placed on them is an added struggle that is something no one should have to deal with. Your gracious gift of information is so helpful. We appreciate and support all of your efforts. We are GRACE because of people like you.
The GRACE Staff
***would you like to volunteer with GRACE? Fill out this volunteer form and a member of our team will get back to you!
Please feel free to offer comments and raise questions in our
discussion forums.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.